Electromed, Inc.ELMDEarnings & Financial Report
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
Revenue
$13.9M
Gross Profit
$10.4M
Operating Profit
$1.8M
Net Profit
$1.5M
Gross Margin
74.8%
Operating Margin
13.3%
Net Margin
10.8%
YoY Growth
14.9%
EPS
$0.17
Electromed, Inc. Q3 FY2024 Financial Summary
Electromed, Inc. reported revenue of $13.9M (up 14.9% YoY) for Q3 FY2024, with a net profit of $1.5M (up 38.9% YoY) (10.8% margin). Cost of goods sold was $3.5M, operating expenses totaled $8.5M.
Key Financial Metrics
| Total Revenue | $13.9M |
|---|---|
| Net Profit | $1.5M |
| Gross Margin | 74.8% |
| Operating Margin | 13.3% |
| Report Period | Q3 FY2024 |
Revenue Breakdown
Electromed, Inc. Q3 FY2024 revenue of $13.9M breaks down across 2 segments, led by Home Care at $12.3M (88.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Home Care | $12.3M | 88.6% |
| Other | $1.6M | 11.4% |
Electromed, Inc. Revenue by Segment — Quarterly Trend
Electromed, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Home Care and Other) has evolved quarter over quarter.
| Segment | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 |
|---|---|---|---|---|
| Other | $1.6M | $951.0K | — | $1.6M |
Electromed, Inc. Annual Revenue by Year
Electromed, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $64.0M).
| Year | Annual Revenue |
|---|---|
| 2025 | $64.0M |
| 2024 | $54.7M |
| 2023 | $48.1M |
| 2022 | $41.7M |
Electromed, Inc. Quarterly Revenue & Net Profit History
Electromed, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 FY2026 | $18.9M | +16.3% | $2.8M | 14.6% |
| Q1 FY2026 | $16.9M | +15.1% | $2.1M | 12.6% |
| Q4 FY2025 | $17.4M | +17.3% | $2.2M | 12.7% |
| Q3 FY2025 | $15.7M | +13.1% | $1.9M | 12.1% |
| Q2 FY2025 | $16.3M | +18.7% | $2.0M | 12.1% |
| Q1 FY2025 | $14.7M | +19.0% | $1.5M | 10.0% |
| Q4 FY2024 | $14.8M | +9.0% | $1.8M | 12.3% |
| Q3 FY2024 | $13.9M | +14.9% | $1.5M | 10.8% |
Income Statement
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.9M | $14.8M | $14.7M | $16.3M | $15.7M | $17.4M | $16.9M | $18.9M |
| YoY Growth | 14.9% | 9.0% | 19.0% | 18.7% | 13.1% | 17.3% | 15.1% | 16.3% |
Balance Sheet
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $48.9M | $52.2M | $48.9M | $52.3M | $52.5M | $53.8M | $53.6M | $54.9M |
| Liabilities | $6.4M | $7.7M | $7.4M | $8.7M | $8.5M | $10.6M | $8.9M | $9.5M |
| Equity | $42.5M | $44.5M | $41.5M | $43.6M | $43.9M | $43.2M | $44.7M | $45.4M |
Cash Flow
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $1.4M | $4.5M | $2.3M | $3.2M | $2.1M | $3.9M | $169000 | $3.0M |